M&A
Pfizer Acquires Global Blood Therapeutics and its sickle cell disease expertise for $5.4 billion
2022-08-09
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04